• Citer

Changes in cognitive function over 96 weeks in naive patients randomized to darunavir-ritonavir plus either raltegravir or tenofovir-emtricitabine: A substudy of the NEAT001/ANRS143 trial

par Winston, Alan;Gatell, Jose;Grarup, Jesper;Pozniak, Anton Louis;Babiker, Abdel;Raffi, François;Richert, Laura;Stöhr, Wolfgang;Antinori, Andrea;Amieva, Hélène;Perre, Philippe;De Wit, Stéphane ;Reynes, Jacques;Gompels, Mark;d'Arminio Monforte, Antonella
Référence Journal of acquired immune deficiency syndromes, 74, 2, page (185-192)
Publication Publié, 2017-02

Article révisé par les pairs

• Détails
• Contenu

Titre:	Changes in cognitive function over 96 weeks in naive patients randomized to darunavir-ritonavir plus either raltegravir or tenofovir-emtricitabine: A substudy of the NEAT001/ANRS143 trial
Auteur:	Winston, Alan; Gatell, Jose; Grarup, Jesper; Pozniak, Anton Louis; Babiker, Abdel; Raffi, François; Richert, Laura; Stöhr, Wolfgang; Antinori, Andrea; Amieva, Hélène; Perre, Philippe; De Wit, Stéphane; Reynes, Jacques; Gompels, Mark; d'Arminio Monforte, Antonella
Informations sur la publication:	Journal of acquired immune deficiency syndromes, 74, 2, page (185-192)
Statut de publication:	Publié, 2017-02
Sujet CREF:	Pharmacologie
	Pathologie maladies infectieuses
Mots-clés:	Antiretroviral therapy
	Cognitive function
	HIV
	Nucleoside sparing
	Randomized clinical trial
Note générale:	SCOPUS: cp.j
Langue:	Anglais
Identificateurs:	urn:issn:1525-4135
	info:doi/10.1097/QAI.0000000000001189
	info:scp/84991497551